Mannkind Corp

NASDAQ: MNKD
$4.39
+$0.01 (+0.2%)
Closing price May 3, 2024

MNKD Articles

The November 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The October 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The October 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The September 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in...
MannKind shares are continuing their rally from Tuesday when it was announced that United Therapeutics was licensing MannKind a dry powder formulation of treprostinil, the active ingredient in...
The August 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Mannkind, Tesaro, Acadia Pharmaceuticals, and Diebold Nixdorf all posted new 52-week lows Monday.
Symantec, Tesaro, Mannkind, and Western Digital all posted new 52-week lows Friday.
The July 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The June 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest moves...